Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003.

Martin M, Vanichseni S, Suntharasamai P, Mock PA, van Griensven F, Pitisuttithum P, Tappero JW, Chiamwongpaet S, Sangkum U, Kitayaporn D, Gurwith M, Choopanya K; Bangkok Vaccine Evaluation Group.

Int J Drug Policy. 2010 Jul;21(4):296-301. doi: 10.1016/j.drugpo.2009.12.002. Epub 2010 Jan 15.

PMID:
20079620
2.

Oral substitution treatment of injecting opioid users for prevention of HIV infection.

Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD004145. doi: 10.1002/14651858.CD004145.pub4. Review.

PMID:
21833948
3.

Substitution treatment of injecting opioid users for prevention of HIV infection.

Gowing L, Farrell M, Bornemann R, Sullivan L, Ali R.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD004145. doi: 10.1002/14651858.CD004145.pub3. Review. Update in: Cochrane Database Syst Rev. 2011;(8):CD004145.

PMID:
18425898
4.

Substitution treatment of injecting opioid users for prevention of HIV infection.

Gowing L, Farrell M, Bornemann R, Ali R.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004145. Review. Update in: Cochrane Database Syst Rev. 2008;(2):CD004145.

PMID:
15495080
5.

Meth/amphetamine use and associated HIV: Implications for global policy and public health.

Degenhardt L, Mathers B, Guarinieri M, Panda S, Phillips B, Strathdee SA, Tyndall M, Wiessing L, Wodak A, Howard J; Reference Group to the United Nations on HIV and injecting drug use.

Int J Drug Policy. 2010 Sep;21(5):347-58. doi: 10.1016/j.drugpo.2009.11.007. Epub 2010 Feb 1. Review.

PMID:
20117923
6.

HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities.

Des Jarlais DC, Arasteh K, Semaan S, Wood E.

Curr Opin HIV AIDS. 2009 Jul;4(4):308-13. doi: 10.1097/COH.0b013e32832bbc6f. Review.

PMID:
19532069
7.

HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998-2007.

Rahimi-Movaghar A, Amin-Esmaeili M, Haghdoost AA, Sadeghirad B, Mohraz M.

Int J Drug Policy. 2012 Jul;23(4):271-8. doi: 10.1016/j.drugpo.2011.09.002. Epub 2011 Oct 14. Review.

PMID:
22000694
8.

Behavioral factors affecting HIV prevention for adolescent and young adult IDUs.

Morse EV, Morse PM, Burchfiel KE, Zeanah PD.

J Assoc Nurses AIDS Care. 1998 May-Jun;9(3):77-90. Review.

PMID:
9589423
9.

Heroin injecting and the introduction of HIV/AIDS into a Scottish city.

Robertson R, Richardson A.

J R Soc Med. 2007 Nov;100(11):491-4. Review. No abstract available.

10.

Racial and ethnic disparities and implications for the prevention of HIV among persons who inject drugs.

Jarlais DC, Cooper HL, Bramson H, Deren S, Hatzakis A, Hagan H.

Curr Opin HIV AIDS. 2012 Jul;7(4):354-61. doi: 10.1097/COH.0b013e328353d990. Review.

PMID:
22498481
11.

HIV and club drugs in emerging adulthood.

Zuckerman MD, Boyer EW.

Curr Opin Pediatr. 2012 Apr;24(2):219-24. doi: 10.1097/MOP.0b013e32834faa9b. Review.

PMID:
22227785
12.

[Dynamics of contracting HIV seen in its social, environmental and cultural dimension].

Gala Gonzalez A, Berdasquera Corcho D, Pérez Avila J, Pinto Valluerca J, Suárez Valdéz J, Joanes Fiol J, Sánchez L, Aragonés López C, Díaz González M.

Rev Cubana Med Trop. 2007 May-Aug;59(2):90-7. Review. Spanish.

PMID:
23427440
Items per page

Supplemental Content

Write to the Help Desk